The facts are grim: One person dies from cardiovascular disease every 37 seconds in the United States. One of the most effective tests for the heart is the twelve-lead electrocardiogram (ECG).
Many fields of medicine are undergoing a transformation due to the COVID-19 pandemic, as patients are kept away from clinics as much as possible.
Las Vegas-- 01/11/2019 -- QT Medical announces the launch of its Personal Cardiac Assistant (PCA 500) at the world’s largest technology showcase, CES. PCA 500 is the only FDA-cleared, hospital quality 12-lead electrocardiogram (ECG) for personal use. QT Medical’s CEO Dr. Ruey-Kang Chang and his team exhibited the PCA 500 at the startup zone in Eureka Park.
QT ECG is selected to be among 4 Finalists in the Life Science Research Tools and Medical Device Category
Dr Ruey-Kang Chang, CEO of QT Medical, garners praise at the Venture Capital Summit held in New York
QT Medical aims to bridge the gap between patients and healthcare providers using their cloud-based 12-lead ECG system to bring high quality cardiac care to homes.
QT Medical, Inc., one of the six finalists, has won the People’s Choice Award in the American Telemedicine Association’s 2018 Pitch Jam competition taking place at the end of April 2018 in Chicago, IL, USA.
Mountain View, California, September 26, 2017 – QT Medical, the leader in ECG technology, has announced that its CEO, Dr. Ruey-Kang Chang, has been awarded the grand prize of Digital Health Challenge - a competition held by MedImmune. The competition was part of the Digital Health Transforming Drug Development Translational Science Forum, hosted annually by MedImmune, the global biologics research and development arm of AstraZeneca.